Vildagliptin Versus Liraglutide - Patient Preference After Receiving Both Medications

NCT01518101 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

62

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes

Interventions

DRUG: Vildagliptin/ Metformin
DRUG: Liraglutide
DRUG: Metformin

Sponsor

Novartis Pharmaceuticals